Replies to post #20733 on DNA Brands Inc (DNAX)

[BizManCali]

Excellent post Ed! How could Mel not through caution to the wind after what happened last year. I can completely understand why things have been silent since there probably isn't anything to say yet other than there still working on eliminating debt which was one of their goals for the 1st quarter of this year. No way is a new product going to launch this quickly even if they had the funds to do so. Hey, I have been here since Feb, 2014 and own a small percentage of my shares above 2 cents which I never sold because I have this much belief in a rebound. Is it a risk? Of course it is but what stock at 0.0001 isn't. With this said, DNA has a real product on the market and are not attempting to build a company off of hype. I still feel good about there future, a risk I'm willing to take and the patients to wait this out.

[Mr. Obvious]

The shareholder letter also clearly states that DNA management would LIKE TO move forward on a new beverage, and that IF they are able to secure funding, they will have the product ready for market in 6-8 months. [Note that the January PR modified this slightly to indicate 6-9 months.] It is very clear that without funding, the work on the new beverage will NOT begin.

Where does this say they cannot begin clinical trials before they secure funding? You to are guilty of putting words in their mouths.

We plan to move forward to COMPLETE the development of a new proprietary functional beverage. The new product has the support of a prominent member of the medical community to do a clinical study at little cost to the Company. With adequate funding, which is not a certainty, we hope to have this product ready for market in 6-9 months.

This clearly says to COMPLETE the product, not to begin the product. Clinical trials need to happen to show results before any large amount of funding will be secured.

Based on the history of other attempts to secure funding purely for "clinical trials" as you are stating, the odds are NOT GOOD for gathering funding. Generally a company will conduct clinical trials so something tangible can be given to investors to secure funding the production and final development stages of a product, such as production runs and distribution. It is VERY rare for people to throw adequate amounts of capital purely for clinical trials to see if an idea may or may not work. Review Kickstarter or Indiegogo campaigns.
http://scopeblog.stanford.edu/2015/02/13/a-look-at-crowdfunding-clinical-trials/

However... there are alternate routes DNA could take to secure funding the trials such as MedStartr and others. BUT, as I have stated before, TELL US THE DAMN PLAN if we are to back this idea. Why keep everything so secretive?

In short, we need an update. Not another vague repeating dialogue from last year. Tell us what has happened now that the 1st quarter has passed.

Have clinical trials begun?

How much debt was paid off?

Has a lawsuit been started or is this still just a "threat"?

Do they still have product I can buy? I have sent orders and emails and no longer receive emails back. I have a track record of 5 previous shipments so why not respond to me if we indeed still have 3 products?

What is our current OS? Obviously we have been extremely diluted. How much more would pay off debt?

These are not ridiculous questions and every investor deserves to know at least 1 of these answers.